SLC8A3
Basic information
Region (hg38): 14:70044215-70189480
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC8A3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 7 | |||||
missense | 53 | 57 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 54 | 5 | 6 |
Variants in SLC8A3
This is a list of pathogenic ClinVar variants found in the SLC8A3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-70045982-T-C | not specified | Uncertain significance (May 04, 2022) | ||
14-70045983-G-A | Likely benign (Dec 19, 2017) | |||
14-70046073-G-T | not specified | Uncertain significance (Aug 02, 2021) | ||
14-70046172-C-G | Benign (Dec 31, 2019) | |||
14-70046261-C-T | not specified | Uncertain significance (Nov 18, 2022) | ||
14-70046282-C-A | not specified | Uncertain significance (Jun 13, 2024) | ||
14-70046302-G-C | not specified | Uncertain significance (Oct 12, 2022) | ||
14-70048761-T-C | Uncertain significance (Dec 17, 2020) | |||
14-70048788-C-T | not specified | Uncertain significance (Sep 28, 2022) | ||
14-70048859-A-G | not specified | Uncertain significance (Aug 30, 2021) | ||
14-70048895-A-G | not specified | Uncertain significance (Jul 26, 2022) | ||
14-70048896-C-T | not specified | Uncertain significance (Oct 27, 2022) | ||
14-70048984-G-A | Likely benign (Jan 03, 2019) | |||
14-70049016-C-T | not specified | Uncertain significance (Nov 13, 2023) | ||
14-70049034-C-T | not specified | Uncertain significance (Nov 21, 2022) | ||
14-70051035-A-G | not specified | Uncertain significance (Feb 15, 2023) | ||
14-70051107-T-C | not specified | Uncertain significance (Nov 21, 2022) | ||
14-70052093-G-T | not specified | Uncertain significance (Jun 02, 2023) | ||
14-70052100-T-C | not specified | Uncertain significance (Jul 20, 2022) | ||
14-70055810-A-C | not specified | Uncertain significance (Feb 11, 2022) | ||
14-70055813-G-A | not specified | Likely benign (Aug 10, 2023) | ||
14-70060856-C-A | not specified | Uncertain significance (Jan 31, 2024) | ||
14-70166663-A-C | not specified | Uncertain significance (Jul 14, 2021) | ||
14-70166733-C-T | Malignant tumor of prostate | Uncertain significance (-) | ||
14-70166750-G-A | not specified | Uncertain significance (Apr 12, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC8A3 | protein_coding | protein_coding | ENST00000381269 | 7 | 144854 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000734 | 0.999 | 125728 | 0 | 20 | 125748 | 0.0000795 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.417 | 508 | 535 | 0.949 | 0.0000293 | 6106 |
Missense in Polyphen | 181 | 219.14 | 0.82596 | 2431 | ||
Synonymous | -0.108 | 211 | 209 | 1.01 | 0.0000119 | 1874 |
Loss of Function | 3.30 | 11 | 30.8 | 0.358 | 0.00000172 | 353 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000145 | 0.000145 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.0000554 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000106 | 0.000105 |
Middle Eastern | 0.0000554 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Mediates the electrogenic exchange of Ca(2+) against Na(+) ions across the cell membrane, and thereby contributes to the regulation of cytoplasmic Ca(2+) levels and Ca(2+)-dependent cellular processes. Contributes to cellular Ca(2+) homeostasis in excitable cells, both in muscle and in brain. In a first phase, voltage-gated channels mediate the rapid increase of cytoplasmic Ca(2+) levels due to release of Ca(2+) stores from the endoplasmic reticulum. SLC8A3 mediates the export of Ca(2+) from the cell during the next phase, so that cytoplasmic Ca(2+) levels rapidly return to baseline. Contributes to Ca(2+) transport during excitation-contraction coupling in muscle. In neurons, contributes to the rapid decrease of cytoplasmic Ca(2+) levels back to baseline after neuronal activation, and thereby contributes to modulate synaptic plasticity, learning and memory (By similarity). Required for normal oligodendrocyte differentiation and for normal myelination (PubMed:21959935). Mediates Ca(2+) efflux from mitochondria and contributes to mitochondrial Ca(2+) ion homeostasis (By similarity). {ECO:0000250|UniProtKB:S4R2P9, ECO:0000269|PubMed:21959935}.;
- Pathway
- Protein digestion and absorption - Homo sapiens (human);Calcium signaling pathway - Homo sapiens (human);Apelin signaling pathway - Homo sapiens (human);cGMP-PKG signaling pathway - Homo sapiens (human);Olfactory transduction - Homo sapiens (human);Antiarrhythmic Pathway, Pharmacodynamics;Calcium Regulation in the Cardiac Cell;Ion homeostasis;Sodium/Calcium exchangers;Transport of inorganic cations/anions and amino acids/oligopeptides;SLC-mediated transmembrane transport;Transport of small molecules;Cardiac conduction;Muscle contraction;Hemostasis;Reduction of cytosolic Ca++ levels;Platelet calcium homeostasis;Mitochondrial calcium ion transport;Platelet homeostasis
(Consensus)
Recessive Scores
- pRec
- 0.157
Intolerance Scores
- loftool
- 0.388
- rvis_EVS
- -1.06
- rvis_percentile_EVS
- 7.55
Haploinsufficiency Scores
- pHI
- 0.823
- hipred
- Y
- hipred_score
- 0.652
- ghis
- 0.589
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.311
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc8a3
- Phenotype
- homeostasis/metabolism phenotype; muscle phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- hematopoietic progenitor cell differentiation;ion transport;mitochondrial calcium ion transmembrane transport;cellular calcium ion homeostasis;cell communication;learning;memory;regulation of skeletal muscle contraction;telencephalon development;sodium ion transmembrane transport;myelination;oligodendrocyte differentiation;mitochondrial calcium ion homeostasis;regulation of postsynaptic membrane potential;long-term synaptic potentiation;calcium ion transmembrane transport;cellular response to cAMP;cellular response to hypoxia;calcium ion import across plasma membrane;regulation of cardiac conduction;calcium ion export across plasma membrane
- Cellular component
- mitochondrial outer membrane;endoplasmic reticulum membrane;microtubule;plasma membrane;integral component of plasma membrane;sarcoplasm;cell junction;intrinsic component of plasma membrane;neuromuscular junction;sarcolemma;dendritic spine;perikaryon;perinuclear region of cytoplasm;integral component of postsynaptic membrane
- Molecular function
- calcium:sodium antiporter activity;calmodulin binding;metal ion binding;ion antiporter activity involved in regulation of postsynaptic membrane potential